Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer

NCT01797471 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
NSCLC

Interventions

RADIATION: Lattice Extreme Ablative Dose (LEAD) Radiation Therapy

Sponsor

University of Miami